TrialInternational archives of allergy and immunology2013

Immunologic effects of omalizumab in children with severe refractory atopic dermatitis: a randomized, placebo-controlled clinical trial.

Shuba Rajashri Iyengar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.